MOSHKEVICH SOLOMON (PRESIDENT, CLINICALDIAGNOSTICS) sold 14.1% of their position (18.16K shares) of NATERA, INC. on the open market
Open‑market sale worth $5.92M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/4/2026ACC: 0002010019-26-000028
Officer· PRESIDENT, CLINICALDIAGNOSTICS
Since Feb 2026
-18.16K
Net shares
Net seller
$5.92M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
18.16K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−1K
Price / share
$319.76
Trade value
$319.76K
% of position
0.8%
9/1/2026
129.02K→128.02K
Common Stock
Direct
Shares
−1.40K
Price / share
$320.92
Trade value
$449.29K
% of position
1.1%
9/1/2026
128.02K→126.62K
Common Stock
Direct
Shares
−600.00
Price / share
$321.91
Trade value
$193.14K
% of position
0.5%
9/1/2026
126.62K→126.02K
Common Stock
Direct
Shares
−15.16K
Price / share
$326.89
Trade value
$4.96M
% of position
12.0%
9/2/2026
126.02K→110.86K
Total
Net shares
−18.16K
Net value
-$5.92M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | S · Sale | −1K | $319.76 | $319.76K | 0.8% | 129.02K | 128.02K |
| Common Stock Direct | 9/1/2026 | S · Sale | −1.40K | $320.92 | $449.29K | 1.1% | 128.02K | 126.62K |
| Common Stock Direct | 9/1/2026 | S · Sale | −600.00 | $321.91 | $193.14K | 0.5% | 126.62K | 126.02K |
| Common Stock Direct | 9/2/2026 | S · Sale | −15.16K | $326.89 | $4.96M | 12.0% | 126.02K | 110.86K |
| Total | −18.16K | -$5.92M | ||||||
Derivative Transactions0
No derivative transactions reported